Science Abstracts
Management of the side effects of androgen deprivation therapy in men with prostate cancer
February 2012
February 2012
Authors : Thomas W Flaig , L Michael Glodé
Affliation : University of Colorado Denver School of Medicine, Division of Medical Oncology, Department of Medicine, Mail Stop 8117, PO Box 6511, Aurora, CO 80045 Colorado, USA ; ; Thomas.Flaig@UCHSC.edu
DOI : 10.1517/14656566.0.0.346688
Published in : Expert Opin. Pharmacother.
Subject:
Keywords: adverse events , androgen deprivation therapy , gonadotropin-releasing hormone agonist , prostate cancer
Abstract
Please Login to read the full article.
RELATED CONTENT
NEWS
- Iron chelator, prostate cancer conundrum on deck for ODAC
- In bone drug quandary, FDA seeks panel's advice on safety, 'drug holidays'
- US Capitol Capsule: House adopts patent reform, but fee change could be trouble for Senate
- Adverse effects cast doubt over Sanofi's Taxotere follow on Jevtana, says NICE
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
